Archive for: August 2008

HealthDay - Here are some of the latest health and medical news developments, compiled by editors of HealthDay:

HealthDay - Here are some of the latest health and medical news developments, compiled by editors of HealthDay:

Reuters - Use of cholesterol-lowering statin drugs, especially long-term use, appears to raise the risk of prostate cancer among obese men, according to findings of a new study.

HealthDay - THURSDAY, Aug. 21 (HealthDay News) -- Zometa (zoledronic acid) prevented bone loss at 12 months in premenopausal women undergoing chemotherapy after they had surgery for early stage breast cancer, a new study found.

HealthDay - THURSDAY, Aug. 21 (HealthDay News) -- The osteoporosis drug Zometa (zoledronic acid) prevented bone loss at 12 months in premenopausal women undergoing chemotherapy after they had surgery for early stage breast cancer, a new study found.

Reuters - Impotence drugs may be able to help reduce the symptoms caused by enlarged prostates, such as trouble urinating, U.S. researchers reported on Tuesday.

HealthDay - TUESDAY, Aug. 12 (HealthDay News) -- Preliminary research has produced promising findings regarding a possible alternative treatment for people with a common type of lung cancer.

HealthDay - TUESDAY, Aug. 12 (HealthDay News) -- The latest update from a European study that has followed men with prostate cancer for more than a decade leaves the debate about the advantages of aggressive treatment versus "watchful waiting" undecided.

HealthDay - MONDAY, Aug. 11 (HealthDay News) -- One in five men in their 40s has had a prostate-specific antigen (PSA) test in the past year, and young black men are more likely than young white men to have undergone the test, a new analysis shows.

Reuters - New research suggests that roughly one in five American men in their 40s has had a blood test to screen for prostate cancer within the last year. However, screening rates in black men are still considered suboptimal, the investigators say.